Fraunhofer ITEM - pioneers for sustainable health - Fraunhofer ITEM (original) (raw)
© IBT Lower Saxony
News /3.12.2024
Inhale+
Fraunhofer ITEMs spin-off project receives a boost of €1.3 million. The technology aims to revolutionize inhalation therapy for premature babies.
Press Release / Research News /1.8.2024
Toxicological assessment of e-liquids
Project EVape helps improve consumer safety in the e-cigarette segment.
Press release /3.7.2024
DNA, RNA and peptides as storage media
BIOSYNTH – “Modular high-throughput micro-platform for mass data storage of the future from synthetic biology”
© Fraunhofer ITEM
Press release /25.7.2024
First patient dosed
OM Pharma and Fraunhofer ITEM announce initiation of a phase Ia/Ib clinical trial evaluating safety and tolerability of OM-85-Intranasal (IN).
News /16.10.2024
Revision of TRGS 529
Researchers at Fraunhofer ITEM are using biological tests to investigate the safety of trace element products for biogas plants.
Press release /16.4.2024
Miniature Lab
New opportunity for cancer therapy: Miniature Lab provides insights into metastases development.
22.3.2024
EU project REGENERAR
3 million euros allocated for research into the development of innovative technologies for brain regeneration.
Press release /1.2.2024
RNAi therapy for viral respiratory diseases
The iGUARD Project have made significant progress in developing a new antiviral therapy.
We keep you posted
Our research and development expertise
For more than four decades, we have been developing solutions for human health
© Fraunhofer ITEM, Felix Schmitt
Lung research
Research for healthy lungs: Airway research has been a focus at Fraunhofer ITEM ever since the institute was founded.
Medical and pharmaceutical engineering
Next to innovative inhalation technologies, our focus is on developing novel technologies for administration of therapeutic aerosols by means of smart drug/device combination products.
© Fraunhofer ITEM
Malignant disease research
The Fraunhofer ITEM Division of Personalized Tumor Therapy in Regensburg is aimed at understanding a patient’s individual condition, establishing appropriate diagnostics and optimizing therapies.
Bioinformatics and AI
Our researchers develop methods for preparation, analysis and visualization of biomedical data, as well as data models and data analysis pipelines. The focus is on the mapping of cellular and regulatory processes and their translation into applications.
© CROCOTHERY, adobe.stock.com
RNA technologies
RNA-based therapeutics are a drug class with huge potential for medicine. Fraunhofer ITEM researchers develop novel drugs and methods for RNA-based therapeutic concepts.
© Fraunhofer ITEM, Ralf Mohr
Toxicology
Based on the next generation risk assessment concept, Fraunhofer ITEM develops new assessment strategies to provide predictive models for assessing the safety of compounds, active pharmaceutical ingredients and drugs.
© Fraunhofer ITEM, Ralf Mohr
Immunology and infection research
The development, formulation and mode of delivery of anti-infective agents, for example for inhaled administration as drug aerosols, are research topics of current interest at the institute.
Our services
Drug Development
© Fraunhofer ITEM
Chemical Safety and Assessment
© Fraunhofer ITEM
Translational Biomedical Engineering
© Fraunhofer ITEM, P. Reinig
Personalized Tumor Therapy
© Fraunhofer ITEM
Meet Fraunhofer ITEM at fairs and congresses
19.6.2025
Save the date - Models of Lung Disease 2025
June 19 and 20 - our conference "Models of Lung Disease" for experts in lung reserach. Please save the date for the 23rd Fraunhofer Seminar "Models of Lung Disease". Join us! We would be pleased to welcoming you there.
3.12.2024
In-silico toxicology training course 2024
Learn more about in-silico methods in toxiicology testing in this two-day taining course at Fraunhofer ITEM in Hannover (DE).
12.11.2024
LION Conference 2024
The Leipzig Immune Oncology (LION) Conference 2024 will be held in Leipzig (Germany) from November 12 to 13, 2024. Scientists from Fraunhofer ITEM will contribute one presentation and four posters.
4.11.2024
BIO-Europe 2024
The international gathering of biopharma professionals BIO-Europe® will take place in Stockholm, Sweden, from November 4 to 6, 2024.
About Fraunhofer ITEM
The Fraunhofer Institute for Toxicology and Experimental Medicine ITEM is one of 76 institutes and research institutions of the Fraunhofer-Gesellschaft, the world’s leading applied research organization. Protecting man from health hazards in our industrialized world and contributing to the development of novel therapeutic approaches are the aims Fraunhofer ITEM is pursuing with its contract research. With a focus on lung research, our R&D portfolio includes three business areas: Drug Development, Chemical Safety and Translational Biomedical Engineering. In addition, our scientists in Regensburg do research in the field of personalized tumor therapy.
With a staff of around 450 at its locations in Hannover, Braunschweig and Regensburg, the institute cooperates with industry, service providers, and public authorities in projects that drive economic development and serve the wider benefit of society.